Skip to content

Study on the Construction and Application of a Large Model Corpus for Pancreatic Cancer Based on Real Clinical Cases

Study on the Construction and Application of a Large Model Corpus for Pancreatic Cancer Based on Real Clinical Cases

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07713823
Enrollment
3000
Registered
2026-07-20
Start date
2026-08-01
Completion date
2028-05-31
Last updated
2026-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer, Pancreatic Cancer Metastatic, Pancreatic Cancer Non-resectable, Pancreatic Cancer Resectable

Brief summary

Combining retrospective observational research with artificial intelligence data engineering. Collecting historical electronic medical record data, and through data governance and annotation by artificial medical experts, constructing a structured knowledge base.

Interventions

None listed

Sponsors

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Real inpatient cases of pancreatic cancer diagnosis and treatment; 2. Prioritize the inclusion of cases with MDT discussion records, difficult and complex cases, and fatal cases; 3. Possess complete electronic medical information (including but not limited to: outpatient medical records, inpatient medical records including admission records, progress notes, surgery/procedure records, nursing records, examination and test reports, doctor's orders, discharge/death records, etc.); -

Exclusion criteria

1. Cases that only underwent a brief transition in emergency/outpatient departments and did not form a closed loop of diagnosis and treatment; 2. Cases with incomplete diagnosis and treatment information and missing key indicators.

Design outcomes

Primary

MeasureTime frame
3,000 Cases of Pancreatic Cancer Diagnosis and TreatmentMay 2028

Contacts

CONTACTLong Jiang, MD
jiang.long@shgh.cn18017317460

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 22, 2026